Loading...

APC anti-mouse CD3 Antibody APC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100235 25 µg NOK273
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100236 100 µg NOK636
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  2. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  3. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  4. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  5. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  6. Liu J, et al. 2019. Immunity. 50:600. PubMed
  7. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  8. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  9. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  10. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  11. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  12. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  13. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  14. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  15. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  16. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  17. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  18. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  19. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  20. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  21. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  22. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  23. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  24. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  25. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  26. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  27. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  28. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  29. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  30. Li X, et al. 2022. Cell. 185:1709. PubMed
  31. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  32. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  33. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  34. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  35. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  36. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  37. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  38. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  39. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  40. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  41. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  42. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  43. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  44. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  45. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  46. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  47. Cansever D, et al. 2023. Nat Immunol. . PubMed
  48. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  49. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  50. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  51. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  52. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  53. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  54. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  55. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  56. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  57. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  58. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  59. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  60. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  61. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  62. Baram T, et al. 2021. Cells. 10:. PubMed
  63. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  64. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  65. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  66. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  68. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  69. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  70. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  71. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  72. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  73. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  74. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  75. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  76. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  77. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  78. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  79. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  80. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  81. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  82. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  83. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  84. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  85. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  86. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  87. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  88. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  89. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  90. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  91. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  92. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  93. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  94. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  95. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  96. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  97. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  98. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  99. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  100. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  101. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  102. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  103. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  104. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  105. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  106. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  107. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  108. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  109. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  110. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  111. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  112. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  113. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  114. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  115. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  116. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  117. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  118. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  119. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  120. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  121. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  122. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  123. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  124. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  125. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  126. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  127. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  128. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  130. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  131. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  132. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  133. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  134. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  135. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  136. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  137. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  138. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  139. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  140. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  141. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  142. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  143. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  144. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  145. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  146. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  147. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  148. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  149. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  150. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  151. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  152. Zhang J, et al. 2018. Nature. 553:91. PubMed
  153. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  154. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  155. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  156. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  157. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  158. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  159. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  160. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  161. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  162. Kim S, et al. 2020. Autophagy. :1. PubMed
  163. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  164. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  165. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  166. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  167. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  168. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  169. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  170. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  173. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  174. Li H, et al. 2022. iScience. 25:104481. PubMed
  175. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  176. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  177. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  178. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  179. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  180. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  181. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  182. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  183. Zeng A, et al. 2020. Oncol Rep. . PubMed
  184. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  185. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  186. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  187. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  188. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  189. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  190. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  191. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  192. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  193. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  194. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  195. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  196. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  197. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  198. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  199. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  200. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  201. Liu J, et al. 2019. Immunity. 50:600. PubMed
  202. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  203. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  204. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  205. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  206. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  207. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  208. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  209. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  210. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  211. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  212. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  213. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  214. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  215. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  216. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  217. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  218. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  219. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  220. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  221. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  222. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  223. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  224. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  225. Li X, et al. 2022. Cell. 185:1709. PubMed
  226. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  227. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  228. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  229. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  230. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  231. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  232. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  233. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  234. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  235. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  236. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  237. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  238. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  239. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  240. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  241. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  242. Cansever D, et al. 2023. Nat Immunol. . PubMed
  243. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  244. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  245. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  246. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  247. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  248. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  249. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  250. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  251. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  252. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  253. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  254. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  255. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  256. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  257. Baram T, et al. 2021. Cells. 10:. PubMed
  258. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  259. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  260. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  261. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  262. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  263. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  264. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  265. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  266. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  267. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  268. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  269. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  270. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  271. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  272. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  273. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  274. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  275. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  276. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  277. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  278. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  279. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  280. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  281. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  282. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  283. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  284. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  285. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  286. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  287. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  288. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  289. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  290. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  291. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  292. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  293. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  294. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  295. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  296. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  297. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  298. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  299. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  300. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  301. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  302. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  303. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  304. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  305. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  306. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  307. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  308. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  309. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  310. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  311. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  312. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  313. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  314. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  315. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  316. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  317. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  318. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  319. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  320. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  321. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  322. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  323. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  324. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  325. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  326. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  327. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  328. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  329. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  330. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  331. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  332. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  333. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  334. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  335. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  336. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  337. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  338. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  339. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  340. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  341. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  342. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  343. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  344. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  345. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  346. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  347. Zhang J, et al. 2018. Nature. 553:91. PubMed
  348. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  349. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  350. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  351. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  352. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  353. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  354. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  355. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  356. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  357. Kim S, et al. 2020. Autophagy. :1. PubMed
  358. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  359. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  360. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  361. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  362. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  363. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  364. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  365. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  366. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  367. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  368. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  369. Li H, et al. 2022. iScience. 25:104481. PubMed
  370. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  371. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  372. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  373. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  374. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  375. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  376. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  377. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  378. Zeng A, et al. 2020. Oncol Rep. . PubMed
  379. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  380. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  381. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  382. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  383. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  384. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  385. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  386. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  387. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  388. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  389. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  390. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
Spark NIR™ 685 anti-mouse CD3 17A2 FC
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Test 17A2 5 17A2
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100235 25 µg NOK273
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100236 100 µg NOK636
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  2. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  3. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  4. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  5. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  6. Liu J, et al. 2019. Immunity. 50:600. PubMed
  7. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  8. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  9. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  10. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  11. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  12. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  13. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  14. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  15. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  16. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  17. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  18. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  19. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  20. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  21. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  22. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  23. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  24. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  25. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  26. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  27. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  28. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  29. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  30. Li X, et al. 2022. Cell. 185:1709. PubMed
  31. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  32. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  33. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  34. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  35. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  36. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  37. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  38. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  39. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  40. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  41. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  42. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  43. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  44. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  45. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  46. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  47. Cansever D, et al. 2023. Nat Immunol. . PubMed
  48. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  49. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  50. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  51. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  52. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  53. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  54. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  55. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  56. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  57. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  58. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  59. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  60. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  61. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  62. Baram T, et al. 2021. Cells. 10:. PubMed
  63. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  64. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  65. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  66. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  68. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  69. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  70. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  71. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  72. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  73. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  74. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  75. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  76. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  77. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  78. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  79. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  80. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  81. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  82. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  83. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  84. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  85. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  86. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  87. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  88. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  89. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  90. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  91. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  92. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  93. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  94. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  95. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  96. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  97. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  98. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  99. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  100. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  101. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  102. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  103. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  104. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  105. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  106. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  107. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  108. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  109. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  110. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  111. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  112. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  113. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  114. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  115. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  116. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  117. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  118. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  119. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  120. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  121. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  122. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  123. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  124. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  125. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  126. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  127. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  128. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  130. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  131. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  132. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  133. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  134. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  135. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  136. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  137. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  138. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  139. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  140. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  141. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  142. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  143. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  144. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  145. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  146. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  147. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  148. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  149. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  150. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  151. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  152. Zhang J, et al. 2018. Nature. 553:91. PubMed
  153. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  154. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  155. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  156. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  157. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  158. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  159. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  160. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  161. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  162. Kim S, et al. 2020. Autophagy. :1. PubMed
  163. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  164. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  165. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  166. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  167. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  168. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  169. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  170. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  173. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  174. Li H, et al. 2022. iScience. 25:104481. PubMed
  175. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  176. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  177. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  178. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  179. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  180. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  181. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  182. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  183. Zeng A, et al. 2020. Oncol Rep. . PubMed
  184. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  185. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  186. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  187. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  188. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  189. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  190. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  191. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  192. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  193. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  194. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  195. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  196. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  197. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  198. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  199. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  200. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  201. Liu J, et al. 2019. Immunity. 50:600. PubMed
  202. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  203. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  204. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  205. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  206. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  207. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  208. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  209. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  210. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  211. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  212. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  213. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  214. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  215. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  216. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  217. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  218. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  219. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  220. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  221. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  222. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  223. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  224. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  225. Li X, et al. 2022. Cell. 185:1709. PubMed
  226. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  227. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  228. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  229. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  230. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  231. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  232. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  233. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  234. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  235. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  236. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  237. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  238. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  239. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  240. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  241. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  242. Cansever D, et al. 2023. Nat Immunol. . PubMed
  243. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  244. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  245. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  246. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  247. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  248. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  249. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  250. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  251. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  252. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  253. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  254. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  255. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  256. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  257. Baram T, et al. 2021. Cells. 10:. PubMed
  258. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  259. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  260. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  261. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  262. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  263. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  264. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  265. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  266. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  267. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  268. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  269. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  270. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  271. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  272. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  273. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  274. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  275. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  276. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  277. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  278. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  279. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  280. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  281. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  282. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  283. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  284. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  285. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  286. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  287. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  288. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  289. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  290. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  291. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  292. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  293. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  294. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  295. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  296. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  297. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  298. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  299. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  300. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  301. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  302. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  303. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  304. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  305. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  306. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  307. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  308. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  309. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  310. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  311. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  312. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  313. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  314. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  315. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  316. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  317. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  318. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  319. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  320. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  321. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  322. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  323. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  324. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  325. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  326. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  327. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  328. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  329. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  330. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  331. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  332. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  333. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  334. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  335. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  336. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  337. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  338. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  339. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  340. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  341. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  342. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  343. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  344. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  345. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  346. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  347. Zhang J, et al. 2018. Nature. 553:91. PubMed
  348. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  349. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  350. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  351. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  352. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  353. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  354. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  355. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  356. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  357. Kim S, et al. 2020. Autophagy. :1. PubMed
  358. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  359. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  360. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  361. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  362. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  363. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  364. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  365. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  366. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  367. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  368. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  369. Li H, et al. 2022. iScience. 25:104481. PubMed
  370. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  371. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  372. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  373. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  374. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  375. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  376. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  377. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  378. Zeng A, et al. 2020. Oncol Rep. . PubMed
  379. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  380. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  381. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  382. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  383. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  384. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  385. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  386. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  387. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  388. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  389. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  390. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
Spark NIR™ 685 anti-mouse CD3 17A2 FC
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Test 17A2 5 17A2
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account